It was not until recently that the role of vitamin C has been of interest again after a preclinical mice study (18) showed that high-dose vitamin C is selectively lethal to KRAS and BRAF mutant colorectal cancer cells by targeting the glutathione (GAPDH) pathway. The gene discussed is KRAS; the disease is colorectal cancer.